Medical Device and Diagnostic Industry (MD+DI)

MiniMed Emerges as the Only Full-Stack Diabetes Tech Player in a $18B Market

Discover how MiniMed's full-stack diabetes technology and global reach post-IPO could transform a rapidly growing $18B ...
FierceBiotech

2023 forecast: A closed loop of upgraded sensors and algorithms could 'put diabetes in the background'

During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha ...
Medscape

FDA Okays Tidepool Loop App to Help Guide Insulin Delivery

The US Food and Drug Administration (FDA) has cleared the Tidepool Loop, a mobile application for use with compatible continuous glucose monitors (CGMs) and insulin pumps to enable automated insulin ...
The New England Journal of Medicine

Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes

The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...
Healio

FDA clears next-generation insulin pump with algorithm-based insulin dosing software

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the iLet ACE insulin pump and iLet dosing decision software for people with type 1 diabetes. The ...
Nature

The year of transition from research to clinical practice

The artificial pancreas — the automated closed-loop control of diabetes mellitus — made its first outpatient strides in 2011. In 2017, the results of long-term clinical trials on the artificial ...